The World Health Organization (WHO) Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP) reports continuously high levels of ceftriaxone resistance across Viet Nam, 2024
- PMID: 41140782
- PMCID: PMC12547025
- DOI: 10.1016/j.lanwpc.2025.101709
The World Health Organization (WHO) Enhanced Gonococcal Antimicrobial Surveillance Programme (EGASP) reports continuously high levels of ceftriaxone resistance across Viet Nam, 2024
Conflict of interest statement
We declare no competing interest.
Figures
References
-
- Jensen J.S., Unemo M. Antimicrobial treatment and resistance in sexually transmitted bacterial infections. Nat Rev Microbiol. 2024;22:435–450. - PubMed
-
- van der Veen S. Global transmission of the penA allele 60.001–containing high-level ceftriaxone-resistant gonococcal FC428 clone and antimicrobial therapy of associated cases: a review. Infect Microb Dis. 2023;2:13–20.
-
- WHO Enhanced gonococcal antimicrobial surveillance programme (EGASP): general protocol. 2021. https://www.who.int/publications/i/item/9789240021341
Publication types
LinkOut - more resources
Full Text Sources
